Biological Intellectual Property Protection Act of 2025
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.
Summary
The bill adds a new licensing requirement to the Export Control Reform Act, so any digital synthetic DNA or RNA sequence sent abroad or shared with a foreign entity of concern must have a U.S. government license. It targets foreign governments, companies, or persons linked to countries deemed a security risk, primarily China, to protect U.S. biotech intellectual property. The measure reflects congressional worries that China could steal biotech data to boost its military and surveillance capabilities.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Track this bill
Get real-time alerts when HR 6624 changes status, plus AI-powered summaries and stage predictions.
Sign up free